Liquid Biopsy Predicts Resistance to Neoadjuvant Therapy in Esophageal Cancer Liquid Biopsy Predicts Resistance to Neoadjuvant Therapy in Esophageal Cancer
Researchers have developed and validated a liquid biopsy assay that can predict response to neoadjuvant therapy in patients with esophageal squamous-cell carcinoma, which may lead to more personalized treatment decisions.Reuters Health Information
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | Esophagus Cancer | Gastroenterology | Hematology | Neoadjuvant Therapy | Skin Cancer | Squamous Cell Carcinoma